Pharmabiz

Maha FDA cracks down on blood centres, suspends 34 licences and cancels 4 for violating drug norms

Maha FDA cracks down on blood centres, suspends 34 licences and cancels 4 for violating drug norms: Shardul Nautiyal, Mumbai ...
Pharmabiz

Can-Fite BioPharma receives Australian Patent supporting Namodenoson development and marketing in liver and pancreatic cancer

Can-Fite BioPharma receives Australian Patent supporting Namodenoson development and marketing in liver and pancreatic cancer: Ramat Gan, Israel Wednesday, July 15, 2026, 15:00 Hr ...
Pharmabiz

SMSIMSR in collaboration with Manipal Group of Hospitals hosts International Conference on Robotic & Endoscopic Cardiac Surgery

SMSIMSR in collaboration with Manipal Group of Hospitals hosts International Conference on Robotic & Endoscopic Cardiac Surgery: Our Bureau, Mumbai Wednesday, July 15, 2026, 14:25 ...
Pharmabiz

Innovent Biologics & Spero Therapeutics enter exclusive license for IBI355, a third-generation Fc-silent anti-CD40L antibody

Innovent Biologics & Spero Therapeutics enter exclusive license for IBI355, a third-generation Fc-silent anti-CD40L antibody: San Francisco Wednesday, July 15, 2026, 14:00 Hrs [IS ...
Pharmabiz

India's life sciences sector gathers pace in novel drug discovery: BCG & HealthKois report

India's life sciences sector gathers pace in novel drug discovery: BCG & HealthKois report: Our Bureau, Bengaluru Wednesday, July 15, 2026, 13:50 Hrs [IST] BCG and HealthKois in a ...
Pharmabiz

Cadila Pharmaceuticals reaffirms commitment to patient safety and regulatory compliance

Cadila Pharmaceuticals reaffirms commitment to patient safety and regulatory compliance: Our Bureau, Mumbai Wednesday, July 15, 2026, 13:30 Hrs [IST] Cadila Pharmaceuticals, a lea ...
Pharmabiz

Summit Therapeutics signs agreement to sell phase III asset ridinilazole to Biossil

Summit Therapeutics signs agreement to sell phase III asset ridinilazole to Biossil: Miami Wednesday, July 15, 2026, 18:00 Hrs [IST] Summit Therapeutics Inc., a biopharmaceutical ...
Pharmabiz

US FDA clears Atrium Therapeutics’ IND application for ATR 1072 to treat of PRKAG2 syndrome

US FDA clears Atrium Therapeutics’ IND application for ATR 1072 to treat of PRKAG2 syndrome: San Diego Wednesday, July 15, 2026, 13:00 Hrs [IST] Atrium Therapeutics, Inc., a bio ...
Pharmabiz

Sun Pharma receives approval to market generic semaglutide in South Africa

Sun Pharma receives approval to market generic semaglutide in South Africa: Our Bureau, Mumbai Wednesday, July 15, 2026, 13:40 Hrs [IST] Sun Pharmaceutical Industries Limited anno ...
Pharmabiz

Future of AI in healthcare will focus on technological innovation: Kumar Sinwar

Future of AI in healthcare will focus on technological innovation: Kumar Sinwar: Our Bureau, Mumbai Wednesday, July 15, 2026, 14:15 Hrs [IST] The future of AI in healthcare will d ...
Pharmabiz

WHO issues updated dosing guidance for antiretroviral medicines used in newborns, infants and children

WHO issues updated dosing guidance for antiretroviral medicines used in newborns, infants and children: Geneva Wednesday, July 15, 2026, 10:00 Hrs [IST] The World Health Organizat ...
Pharmabiz

CMC-Vellore & IIIT Hyderabad develop BandhuCare, a multilingual AI companion for cancer patients

CMC-Vellore & IIIT Hyderabad develop BandhuCare, a multilingual AI companion for cancer patients: Our Bureau, Bengaluru Wednesday, July 15, 2026, 14:40 Hrs [IST] Christian Medical ...